Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese concept of ‘sanpro yoshi’. Kemps also explains the importance of Belgium for Nipro, the innovation opportunities in the digitalisation of healthcare, and his strategic priorities since taking on the role of CEO.
Not only do we represent a significant turnover, but often Europe is the trendsetter in terms of new products and procedures [for Nipro]. In this regard, we are well connected to our Japanese headquarters to ensure that these trends are featured in the global strategy
